Jill M. Jene's most recent trade in Lipocine Inc was a trade of 1,764 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lipocine Inc | Jill M. Jene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 1,764 | 7,174 | - | - | Stock Option (Right to Buy) | |
| Lipocine Inc | Jill M. Jene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,764 | 5,410 | - | - | Stock Option (Right to Buy) | |
| Lipocine Inc | Jill M. Jene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 30,000 | 62,000 | - | - | Stock Option (Right to Buy) | |
| Lipocine Inc | Jill M. Jene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 22,000 | 32,000 | - | - | Stock Option (Right to Buy) | |
| Lipocine Inc | Jill M. Jene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |